What Is Radical Trachelectomy?
Radical trachelectomy, also called radical cervicectomy, is a fertility-preserving operation for carefully selected patients with early-stage cervical cancer.
Unlike radical hysterectomy, which removes the uterus and cervix, radical trachelectomy removes the cervix together with surrounding tissues needed for adequate cancer clearance while preserving the main body of the uterus. The remaining uterus is then connected to the upper vagina.
The purpose is to achieve two important goals at the same time:
- Remove the cancer with appropriate surgical margins
- Preserve the possibility of future pregnancy
The operation also includes assessment of the pelvic lymph nodes, because lymph-node involvement can change both the safety of fertility-preserving surgery and the overall treatment plan.
Radical trachelectomy may be performed through a vaginal or abdominal approach, and selected procedures may also be performed using minimally invasive techniques. The most appropriate approach depends on tumor characteristics, anatomy, surgical expertise, and the individual treatment plan.
The operation was pioneered as a fertility-preserving treatment for cervical cancer by Professor Daniel Dargent and has since become an established option for appropriately selected patients who wish to preserve fertility.
Importantly, radical trachelectomy is not appropriate for every young patient with cervical cancer. In some very small tumors, less extensive fertility-preserving treatment may be sufficient, while larger or biologically aggressive cancers may require a different treatment strategy.
The central principle is therefore not simply to preserve the uterus, but to do so without compromising appropriate cancer treatment.
Who May Be a Candidate for Radical Trachelectomy?
Careful patient selection is one of the most important parts of fertility-preserving treatment.
Radical trachelectomy may be considered for selected patients who:
- Have a strong desire to preserve fertility
- Have invasive cervical cancer confined to the cervix
- Have a tumor for which fertility-sparing surgery is considered oncologically appropriate
- Have no evidence of pelvic lymph-node or distant metastases
- Have tumor histology suitable for fertility-preserving treatment
- Have adequate tumor-free cervical tissue toward the uterus to allow safe resection and reconstruction
- Are medically fit for surgery
- Understand the oncological, fertility, and pregnancy implications of treatment
The best-established candidates generally have small early-stage tumors, particularly those measuring 2 cm or less.
Tumor histology is also important. Fertility-preserving surgery is most established for squamous cell carcinoma and usual HPV-associated adenocarcinoma. Certain aggressive or uncommon histological subtypes may not be appropriate for this approach.
Not every early cervical cancer requires radical trachelectomy. For some patients with very small, favorable tumors, conization or another less radical fertility-preserving procedure may provide adequate treatment.
The decision should therefore be based on the individual tumor rather than automatically choosing the most extensive fertility-preserving operation.
What About Tumors Larger Than 2 cm?
Tumor size is an important predictor of both recurrence risk and the likelihood that radical trachelectomy can be completed safely.
For tumors larger than 2 cm, fertility-preserving treatment becomes more complex and should not simply be considered equivalent to treatment of smaller tumors.
Selected patients may be evaluated for individualized fertility-preserving strategies at experienced centers, sometimes incorporating systemic treatment before surgery. However, evidence is more limited, and these approaches require particularly careful multidisciplinary assessment.
The priority must remain oncological safety rather than fertility preservation at any cost.
When May Radical Trachelectomy Not Be Appropriate?
Radical trachelectomy may not be appropriate when the likelihood of adequately treating the cancer while preserving the uterus is too low.
Reasons may include:
- Cancer extending beyond the cervix
- Pelvic lymph-node or distant metastatic disease
- Inability to obtain an adequate cancer-free margin toward the uterus
- Tumor characteristics associated with an unacceptable risk of recurrence
- Histological subtypes for which fertility-preserving surgery is not considered appropriate
- Previous treatment or anatomical factors that make safe reconstruction impractical
- A uterine or reproductive condition that makes meaningful fertility preservation unlikely
- Medical conditions that make the planned operation unsafe
Age alone should not be used as a rigid cutoff. Reproductive potential, ovarian function, fertility goals, tumor characteristics, and overall health are more relevant than a single chronological age threshold.
Similarly, tests such as anti-Müllerian hormone (AMH) may contribute to fertility assessment but should not generally be used as an isolated oncological criterion for determining whether radical trachelectomy can be performed.
For patients who are unlikely to benefit from radical trachelectomy, other fertility-preserving options or standard cervical cancer treatments should be discussed according to the individual situation.
Preoperative Assessment
Before radical trachelectomy, the team must determine whether the cancer can be treated safely while preserving the uterus and whether the patient has a realistic opportunity to benefit from fertility preservation.
Assessment typically includes review of:
- Cervical biopsy or conization pathology
- Tumor size and histological type
- Depth of stromal invasion
- Lymphovascular space invasion (LVSI)
- Surgical margins when a previous conization has been performed
- Pelvic MRI
- Lymph-node status
- Previous cervical procedures
- Reproductive history and fertility goals
Pelvic MRI is particularly useful for defining tumor size, location, stromal involvement, and the relationship between the upper edge of the tumor and the internal cervical os.
Additional imaging or investigations may be required according to the stage, tumor characteristics, and clinical findings.
Because fertility is a central reason for choosing this operation, selected patients may also benefit from consultation with a reproductive endocrinology and infertility specialist before treatment.
This allows ovarian reserve, other potential causes of infertility, and fertility-preservation options to be considered before cancer treatment begins.
Is Lymph-Node Assessment Necessary?
Yes. Regional lymph-node assessment is an essential part of fertility-preserving surgery for invasive cervical cancer when radical trachelectomy is being considered.
Imaging can identify suspicious lymph nodes, but it cannot reliably exclude microscopic metastases.
Depending on the individual case and surgical strategy, lymph-node assessment may involve:
- Sentinel lymph-node mapping
- Pelvic lymph-node dissection
- A combination of these approaches
Sentinel lymph-node mapping has become increasingly important in appropriately selected early-stage cervical cancer and may reduce the extent of lymph-node surgery in suitable patients.
If metastatic cancer is identified in the lymph nodes, the planned fertility-preserving operation may need to be abandoned or modified because the patient may require a different treatment strategy.
The exact approach to lymph-node assessment should follow the patient's disease characteristics and current cervical cancer treatment standards.
How Is Radical Trachelectomy Performed?
Radical trachelectomy is performed under general anesthesia.
The precise operation varies according to the surgical approach and the extent of resection required.
In an abdominal radical trachelectomy, the surgeon first evaluates the pelvis and performs the planned lymph-node assessment. If findings remain suitable for fertility-preserving surgery, the operation proceeds.
The cervix is removed together with the amount of surrounding parametrial tissue and upper vagina required for adequate oncological clearance. The main body of the uterus is preserved.
During surgery, particular attention is given to obtaining an adequate tumor-free margin between the cancer and the remaining uterus.
When appropriate, intraoperative pathological assessment may be used to evaluate the surgical margin and lymph nodes.
After the cervix has been removed, the remaining uterus is connected to the vagina to restore continuity of the reproductive tract.
A permanent cerclage may be placed around the lower uterine segment to provide support during a future pregnancy.
Whenever oncologically and technically appropriate, the operation also aims to preserve uterine blood supply and minimize injury to structures involved in bladder, bowel, and sexual function.
Not every patient requires exactly the same degree of radicality. The extent of parametrial resection should be individualized according to tumor characteristics and contemporary oncological principles.
Can Radical Trachelectomy Be Converted to Hysterectomy?
Yes.
Although the operation is planned with the intention of preserving fertility, complete and safe cancer treatment takes priority over preservation of the uterus.
The planned trachelectomy may need to be modified or abandoned if surgery identifies findings such as:
- Lymph-node metastasis
- More extensive cancer than expected
- Inability to obtain an adequate tumor-free margin
- Anatomical findings that prevent safe reconstruction
- Significant compromise of the remaining uterus or its blood supply
- Another unexpected finding that makes fertility-preserving surgery oncologically unsafe
Depending on the situation, this may result in hysterectomy or a different cancer-treatment strategy.
For this reason, the possibility that fertility cannot ultimately be preserved should be discussed before surgery, even when preoperative assessment is favorable.
Why Radical Trachelectomy Requires Specialized Experience
Radical trachelectomy differs from many cancer operations because success cannot be judged by tumor removal alone.
The surgeon must achieve appropriate oncological clearance while preserving a functional uterus and reproductive potential whenever safely possible.
This requires careful judgment regarding:
- Patient selection
- Tumor margins
- Lymph-node assessment
- Extent of parametrial resection
- Uterine blood supply
- Pelvic autonomic nerves
- Uterovaginal reconstruction
- Cerclage placement
- Future fertility and pregnancy
The operation should therefore be performed within a team experienced in gynecologic oncology, fertility-preserving cancer surgery, pathology, reproductive medicine, and high-risk pregnancy care.
Possible Risks and Complications
Radical trachelectomy is major pelvic surgery. Although many patients recover without serious problems, complications can occur.
General surgical risks include:
- Bleeding
- Infection
- Blood clots
- Injury to the bladder, ureters, bowel, nerves, or blood vessels
- Urinary difficulties
- Lymphocele or lower-limb lymphedema after lymph-node surgery
- Wound complications
- Need for another procedure or operation
Because the uterus is preserved and reconnected to the vagina, additional problems may include:
- Narrowing of the reconstructed cervical canal (cervical stenosis)
- Menstrual abnormalities
- Chronic or altered vaginal discharge
- Pelvic adhesions
- Problems related to the cerclage
- Reduced fertility
- Sexual discomfort
- Rare problems affecting uterine blood supply or healing of the reconstruction
The individual risk depends on the surgical approach, extent of lymph-node and parametrial surgery, previous procedures, anatomy, general health, and experience of the treating team.
Recovery After Radical Trachelectomy
Recovery depends on the surgical approach and extent of the operation.
After abdominal radical trachelectomy, patients usually remain in hospital for several days. A urinary catheter may be needed temporarily while bladder function recovers.
Early recovery focuses on:
- Pain control
- Prevention of blood clots
- Early walking
- Return of bladder and bowel function
- Wound care
- Gradual return to normal eating
- Monitoring for infection, bleeding, or other complications
Light everyday activity can usually be resumed gradually as recovery progresses. Heavy lifting, strenuous exercise, and sexual intercourse should be avoided until adequate healing has been confirmed.
Many patients recover substantially over several weeks, although the exact timeline varies.
Your surgical team will provide individualized instructions regarding work, exercise, driving, sexual activity, and fertility planning.
Follow-Up After Radical Trachelectomy
Long-term surveillance is particularly important after fertility-preserving cervical cancer treatment because the cervix has been removed but the uterus and reproductive tract remain.
Follow-up generally includes regular clinical assessment and pelvic examination. Depending on the individual situation, surveillance may also involve cytology, HPV testing, colposcopic assessment, or imaging when clinically indicated.
The exact schedule and tests should be individualized according to the original cancer, pathology findings, treatment received, symptoms, and current surveillance recommendations.
Patients should contact their healthcare team rather than waiting for a scheduled appointment if they develop concerning symptoms such as:
- New or persistent vaginal bleeding
- Unusual discharge
- Persistent pelvic or abdominal pain
- New urinary or bowel symptoms
- Unexplained weight loss
- Other persistent symptoms that are unusual for them
HPV vaccination should also be discussed with eligible patients according to current recommendations.
What Are the Oncological Outcomes?
For appropriately selected patients with early-stage cervical cancer, radical trachelectomy can provide excellent cancer control while preserving the uterus.
The likelihood of recurrence is influenced by several factors, particularly:
- Tumor size
- Histological type
- Lymph-node status
- Surgical margins
- Lymphovascular space invasion
- Depth of stromal invasion
- Other pathological risk factors
Published outcomes are generally favorable in carefully selected patients, particularly for tumors 2 cm or smaller with negative lymph nodes and adequate surgical margins.
However, no operation can guarantee that cervical cancer will not return.
This is why the decision to preserve fertility must begin with appropriate oncological selection and be followed by long-term surveillance.
Fertility After Radical Trachelectomy
Preserving the uterus means that pregnancy remains possible, but radical trachelectomy does not guarantee future fertility.
Some patients conceive naturally after treatment, while others experience difficulty becoming pregnant.
Potential reasons include:
- Cervical stenosis
- Changes in cervical mucus
- Pelvic adhesions
- Changes in the reconstructed cervical canal
- Other pre-existing or treatment-related fertility factors
If pregnancy does not occur naturally, evaluation by a fertility specialist may identify options such as assisted reproductive treatment.
Whenever possible, fertility goals should be discussed before cancer treatment, rather than waiting until pregnancy is desired later.
For selected patients, consultation with a reproductive specialist before surgery can also provide a clearer understanding of ovarian reserve and other factors that may influence future pregnancy.
Can I Become Pregnant After Radical Trachelectomy?
Yes. Many patients have successfully become pregnant and delivered healthy babies after radical trachelectomy.
However, pregnancy after the operation is considered higher risk than pregnancy in the general population.
Potential pregnancy-related problems include:
- Second-trimester pregnancy loss
- Preterm birth
- Premature rupture of membranes
- Ascending infection
- Pregnancy complications related to the shortened or reconstructed cervix
For this reason, pregnancy should ideally be managed jointly with a maternal-fetal medicine or high-risk obstetric team familiar with pregnancy after trachelectomy.
A permanent cerclage is often placed during radical trachelectomy to support future pregnancies.
Despite the additional risks, successful pregnancy is possible for many appropriately selected patients.
When Can I Try to Become Pregnant?
There is no single waiting period that is appropriate for every patient.
Before attempting pregnancy, several issues need to be considered:
- Adequate healing after surgery
- Final pathology results
- Need for any additional cancer treatment
- Early postoperative surveillance
- Fertility and reproductive factors
- Individual recurrence risk
Many teams recommend waiting for a period after treatment before attempting conception, but the timing should be individualized rather than determined by a universal rule.
Patients should discuss pregnancy planning with both their gynecologic oncologist and fertility or obstetric team.
How Will My Baby Be Delivered?
Delivery planning depends partly on the reconstruction performed during radical trachelectomy.
After radical trachelectomy with a permanent cerclage, delivery is generally by cesarean section rather than vaginal birth.
Pregnancy should therefore be managed as a high-risk pregnancy, with delivery planned in advance by the obstetric and gynecologic oncology teams.
The timing of delivery depends on the course of the pregnancy and individual obstetric circumstances.
Should the Uterus Be Removed After Childbearing Is Complete?
Not routinely.
For a patient who remains disease-free, completion hysterectomy is not automatically required simply because she has completed childbearing.
Continued surveillance may be appropriate.
Hysterectomy may nevertheless become appropriate if there is recurrent or persistent disease, concerning abnormalities, significant treatment-related problems, or another gynecological indication for removing the uterus.
The decision should be individualized according to oncological findings, symptoms, reproductive plans, and patient preference.
What Happens If the Cancer Returns?
Recurrence is uncommon in appropriately selected patients, but it remains possible.
Treatment depends on where the cancer returns, its extent, previous treatment, and the patient's overall condition.
Depending on these factors, treatment may involve:
- Surgery
- Hysterectomy or more extensive pelvic surgery in selected situations
- Radiotherapy
- Chemoradiotherapy
- Systemic therapy
- Other disease-specific treatments
Some localized recurrences can still be treated with curative intent.
Long-term surveillance therefore remains an important part of care after fertility-preserving treatment.
Our Approach to Radical Trachelectomy
Fertility preservation should never come at the expense of appropriate cancer treatment.
The first question is therefore whether fertility-preserving surgery is oncologically safe.
The second is how much surgery is actually necessary to treat the cancer adequately.
The third is whether the uterus can be preserved in a way that offers meaningful reproductive potential after treatment.
For each patient, we consider the tumor size, histology, depth of invasion, LVSI, lymph-node status, surgical margins, MRI findings, reproductive goals, ovarian function, and other fertility factors before recommending treatment.
When radical trachelectomy is appropriate, the operation is planned not only to remove the cancer but also to preserve uterine blood supply, reproductive anatomy, and future pregnancy potential whenever oncologically safe.
Equally importantly, patients with very small favorable tumors should not undergo radical surgery when a less extensive fertility-preserving procedure can provide appropriate cancer treatment.
The objective is therefore not to perform radical trachelectomy whenever the uterus can technically be preserved. It is to choose the least extensive treatment that provides appropriate oncological safety while preserving fertility whenever reasonably possible.
Why Choose Prof. Yusuf Yıldırım for Radical Trachelectomy?
Radical trachelectomy requires expertise in both gynecologic cancer surgery and fertility-preserving treatment.
As a specialist in Surgical Oncology and Gynecologic Oncology, Prof. Yusuf Yıldırım, MD has experience in the surgical management of cervical cancer and complex pelvic malignancies, including fertility-preserving surgical approaches.
Prof. Yıldırım introduced abdominal radical trachelectomy into his surgical practice in 2007 and has continued to use fertility-preserving surgery for appropriately selected patients with early cervical cancer.
Each patient is evaluated individually according to the oncological safety of fertility preservation, extent of surgery required, lymph-node status, reproductive goals, and likelihood of preserving meaningful fertility without compromising cancer treatment.
When radical trachelectomy is appropriate, treatment is planned within a multidisciplinary framework that considers not only cancer control, but also future fertility, pregnancy, long-term surveillance, and quality of life.
Second Opinion for Fertility-Preserving Cervical Cancer Treatment
A diagnosis of cervical cancer does not always mean that the uterus must be removed.
For selected patients with early-stage disease, conization, simple trachelectomy, radical trachelectomy, or other individualized fertility-preserving strategies may allow effective cancer treatment while maintaining the possibility of future pregnancy.
At the same time, fertility-preserving surgery is not appropriate for every cervical cancer, and choosing a less extensive operation should never compromise oncological safety.
If you have been advised to undergo hysterectomy but wish to preserve fertility, specialist review of your pathology, imaging, previous cervical procedures, tumor characteristics, and reproductive goals can help determine whether a fertility-preserving approach may be appropriate.
The objective of a second opinion is not necessarily to recommend radical trachelectomy. It is to determine whether fertility can be preserved safely and, if so, what is the least extensive oncologically appropriate treatment for your individual cancer.